Speech News and Research

RSS

Researchers find how different neurons work together to reduce responses to frequent sounds

Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.

12 Oct 2015

New computer program can predict cochlear implant outcomes in hearing-impaired children

A new computer program that analyzes functional brain MRIs of hearing impaired children can predict whether they will develop effective language skills within two years of cochlear implant surgery, according to a study in the journal Brain and Behavior.

12 Oct 2015

Is dyspraxia a battle of the sexes?

New findings released Monday 12 October 2015 have revealed a significant gap in the diagnosis – and therefore, treatment – of dyspraxia, otherwise known as developmental co-ordination disorder (DCD), amongst young women and girls.

12 Oct 2015

Study: Learning complex auditory categories through procedural learning is impaired in dyslexia

The cognitive skills used to learn how to ride a bike may be the key to a more accurate understanding of developmental dyslexia. And, they may lead to improved interventions.

9 Oct 2015

Roy D. Patterson selected to receive ASA's Silver Medal in Psychological and Physiological Acoustics

Roy D. Patterson, Emeritus Professor at the University of Cambridge, Cambridge, UK, has been named recipient of the Acoustical Society of America's Silver Medal in Psychological and Physiological Acoustics for contributions to understanding pitch and timbre perception, and for computational modeling of auditory representations.

9 Oct 2015

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

9 Oct 2015

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).

8 Oct 2015

U of T study provides hope for treating ALS and FTD

It's the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but until now scientists weren't sure how a specific gene caused these devastating diseases. Now researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.

6 Oct 2015

Songbirds may help researchers find cure for Huntington’s disease

Many neurological disorders can rob someone of the ability to speak clearly, causing them to stutter, mispronounce words, and struggle to put together coherent sentences. However, the molecular and neurological dysfunctions that cause these symptoms aren't well understood. Recent work at The Rockefeller University may give researchers a new tool to better study these vocal and speech impairments, particularly in Huntington's disease.

6 Oct 2015

Second major partner for the Advanced Wellbeing Research Centre announced

In a speech at the AWRC conference on the Olympic Legacy Park (OLP), the Minister also outlined Government priorities on tackling obesity and encouraging physical activity - in particular noting the Government's forthcoming new childhood obesity strategy.

5 Oct 2015

Predicting better immunotherapy response, neurological outcomes in adults with autoimmune cerebellar ataxia

While autoimmune cerebellar ataxia (a loss of muscle control coordination) can lead to severe disability with some patients becoming wheelchair-bound, there are factors that may help predict better immunotherapy response, according to the Mayo Clinic study published by JAMA Neurology.

30 Sep 2015

Radical surgery associated with overall survival benefits among patients with advanced throat cancer

Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer Congress today (Saturday).

26 Sep 2015

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

"We are pleased to receive positive CHMP opinions for Kyprolis and BLINCYTO as this is an important step in providing new treatment options for patients in Europe with rare forms of cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.

25 Sep 2015

WSU biomedical students create therapeutic speech development toy for kids with auditory disabilities

Hearing loss is one of the most common birth defects, with more than 12,000 children in the United States affected each year. Three students in Wichita State University's biomedical engineering program recognized this issue and designed their senior project to create a therapeutic toy to provide early intervention therapy for children with auditory disabilities.

24 Sep 2015

Terminally ill patients with certain subtypes of delirium show higher probability of imminent death

In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.

24 Sep 2015

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

To understand deep learning in the context of genetic disease, you need to understand shallow learning first. Shallow learning relates mutations to diseases by looking for mutations that commonly occur in patients with a disease. It’s a commonly used method.

21 Sep 2015

Advances in rehabilitation devices improve quality of life for impaired patients, finds Frost & Sullivan

In today’s increasingly independent and active lifestyle, patients with physical impairment due to age or a strokefeel the need for improved devices capable of helping them lead a quality life.

18 Sep 2015

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

CSUSM gains initial accreditation for Master of Science in Speech-Language Pathology program

California State University San Marcos has earned initial accreditation from the Council on Academic Accreditation (CAA) of the American Speech-Language Hearing Association for the Master of Science in Speech-Language Pathology (SLP) program.

9 Sep 2015

Researchers use stem cell-derived 'mini-brains' to identify drug candidate for rare neurological disorder

Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration.

9 Sep 2015

Speech News and Research

Researchers find how different neurons work together to reduce responses to frequent sounds

New computer program can predict cochlear implant outcomes in hearing-impaired children

Is dyspraxia a battle of the sexes?

Study: Learning complex auditory categories through procedural learning is impaired in dyslexia

Roy D. Patterson selected to receive ASA's Silver Medal in Psychological and Physiological Acoustics

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

U of T study provides hope for treating ALS and FTD

Songbirds may help researchers find cure for Huntington’s disease

Second major partner for the Advanced Wellbeing Research Centre announced

Predicting better immunotherapy response, neurological outcomes in adults with autoimmune cerebellar ataxia

Radical surgery associated with overall survival benefits among patients with advanced throat cancer

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

WSU biomedical students create therapeutic speech development toy for kids with auditory disabilities

Terminally ill patients with certain subtypes of delirium show higher probability of imminent death

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

Advances in rehabilitation devices improve quality of life for impaired patients, finds Frost & Sullivan

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

CSUSM gains initial accreditation for Master of Science in Speech-Language Pathology program

Researchers use stem cell-derived 'mini-brains' to identify drug candidate for rare neurological disorder

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News